Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHASE 4 STUDY OT THE EFFECT OF GLUCOSE ADDED TO THE DIALYSIS FLUID ON BLOOD PRESSURE, BLOOD GLUCOSE AND QUALITY OF LIFE IN HEMODIALYSIS PATIENTS.

NCT00278057 is registered in ClinicalTrials.gov with Regional Hospital Holstebro as lead sponsor.

NCT NCT00278057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00278057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHASE 4 STUDY OT THE EFFECT OF GLUCOSE ADDED TO THE DIALYSIS FLUID ON BLOOD PRESSURE, BLOOD GLUCOSE AND QUALITY OF LIFE IN HEMODIALYSIS PATIENTS.
Lead sponsor
Regional Hospital Holstebro
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2003
Completion date
May 31, 2003
Enrollment
55
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis